\

Sign in

Cancer Immunotherapy Market 2025 - 2035

Request Sample Access TOC

Reports - Cancer Immunotherapy Market

Healthcare

Cancer Immunotherapy Market

Cancer Immunotherapy Market Size and Projected Growth Through 2035 by Product (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines) by Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Ovarian Cancer, Pancreatic Cancer, Other Cancers) by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) by End Use (Hospitals & Clinics, Cancer Research Centers, Other End Uses) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Request Sample Access TOC

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insight View Inclusion

SHARE

Table of Contents

Chapter 1 Executive Dashboard

1. Strategic Imperatives

Chapter 2 Premium Insights

1. Top 3 Trends to Watch

2. Demand and Supply Trends

3. Top 3 Strategies Followed by Major Players

4. Top 3 Predictions by Vantage Market Research

5. Top Investment Pockets

6. Insights from Primary Respondents

Chapter 3 Global Cancer Immunotherapy Market - Segment Analysis

1. Overview

2. Global Cancer Immunotherapy Market, 2021 - 2035 (USD Million)

3. Global Cancer Immunotherapy Market - by Product

3.1. By Monoclonal Antibodies

3.2. By Immunomodulators

3.3. By Oncolytic Viral Therapies & Cancer Vaccines

4. Global Cancer Immunotherapy Market - by Application

4.1. By Lung Cancer

4.2. By Breast Cancer

4.3. By Colorectal Cancer

4.4. By Melanoma

4.5. By Prostate Cancer

4.6. By Head & Neck Cancer

4.7. By Ovarian Cancer

4.8. By Pancreatic Cancer

4.9. By Other Cancers

5. Global Cancer Immunotherapy Market - by Distribution Channel

5.1. By Hospital Pharmacy

5.2. By Retail Pharmacy

5.3. By Online Pharmacy

6. Global Cancer Immunotherapy Market - by End Use

6.1. By Hospitals & Clinics

6.2. By Cancer Research Centers

6.3. By Other End Uses

7. Global Cancer Immunotherapy Market - by region

7.1. North America

7.2. Europe

7.3. Asia Pacific

7.4. Latin America

7.5. Middle East & Africa

8. Market comparative analysis

Chapter 4 North America Cancer Immunotherapy Market - Segment Analysis

1. Overview

2. North America Cancer Immunotherapy Market, 2021 - 2035 (USD Million)

3. North America Cancer Immunotherapy Market - by Product

3.1. By Monoclonal Antibodies

3.2. By Immunomodulators

3.3. By Oncolytic Viral Therapies & Cancer Vaccines

4. North America Cancer Immunotherapy Market - by Application

4.1. By Lung Cancer

4.2. By Breast Cancer

4.3. By Colorectal Cancer

4.4. By Melanoma

4.5. By Prostate Cancer

4.6. By Head & Neck Cancer

4.7. By Ovarian Cancer

4.8. By Pancreatic Cancer

4.9. By Other Cancers

5. North America Cancer Immunotherapy Market - by Distribution Channel

5.1. By Hospital Pharmacy

5.2. By Retail Pharmacy

5.3. By Online Pharmacy

6. North America Cancer Immunotherapy Market - by End Use

6.1. By Hospitals & Clinics

6.2. By Cancer Research Centers

6.3. By Other End Uses

Chapter 5 Europe Cancer Immunotherapy Market - Segment Analysis

1. Overview

2. Europe Cancer Immunotherapy Market, 2021 - 2035 (USD Million)

3. Europe Cancer Immunotherapy Market - by Product

3.1. By Monoclonal Antibodies

3.2. By Immunomodulators

3.3. By Oncolytic Viral Therapies & Cancer Vaccines

4. Europe Cancer Immunotherapy Market - by Application

4.1. By Lung Cancer

4.2. By Breast Cancer

4.3. By Colorectal Cancer

4.4. By Melanoma

4.5. By Prostate Cancer

4.6. By Head & Neck Cancer

4.7. By Ovarian Cancer

4.8. By Pancreatic Cancer

4.9. By Other Cancers

5. Europe Cancer Immunotherapy Market - by Distribution Channel

5.1. By Hospital Pharmacy

5.2. By Retail Pharmacy

5.3. By Online Pharmacy

6. Europe Cancer Immunotherapy Market - by End Use

6.1. By Hospitals & Clinics

6.2. By Cancer Research Centers

6.3. By Other End Uses

Chapter 6 Asia Pacific Cancer Immunotherapy Market - Segment Analysis

1. Overview

2. Asia Pacific Cancer Immunotherapy Market, 2021 - 2035 (USD Million)

3. Asia Pacific Cancer Immunotherapy Market - by Product

3.1. By Monoclonal Antibodies

3.2. By Immunomodulators

3.3. By Oncolytic Viral Therapies & Cancer Vaccines

4. Asia Pacific Cancer Immunotherapy Market - by Application

4.1. By Lung Cancer

4.2. By Breast Cancer

4.3. By Colorectal Cancer

4.4. By Melanoma

4.5. By Prostate Cancer

4.6. By Head & Neck Cancer

4.7. By Ovarian Cancer

4.8. By Pancreatic Cancer

4.9. By Other Cancers

5. Asia Pacific Cancer Immunotherapy Market - by Distribution Channel

5.1. By Hospital Pharmacy

5.2. By Retail Pharmacy

5.3. By Online Pharmacy

6. Asia Pacific Cancer Immunotherapy Market - by End Use

6.1. By Hospitals & Clinics

6.2. By Cancer Research Centers

6.3. By Other End Uses

Chapter 7 Latin America Cancer Immunotherapy Market - Segment Analysis

1. Overview

2. Latin America Cancer Immunotherapy Market, 2021 - 2035 (USD Million)

3. Latin America Cancer Immunotherapy Market - by Product

3.1. By Monoclonal Antibodies

3.2. By Immunomodulators

3.3. By Oncolytic Viral Therapies & Cancer Vaccines

4. Latin America Cancer Immunotherapy Market - by Application

4.1. By Lung Cancer

4.2. By Breast Cancer

4.3. By Colorectal Cancer

4.4. By Melanoma

4.5. By Prostate Cancer

4.6. By Head & Neck Cancer

4.7. By Ovarian Cancer

4.8. By Pancreatic Cancer

4.9. By Other Cancers

5. Latin America Cancer Immunotherapy Market - by Distribution Channel

5.1. By Hospital Pharmacy

5.2. By Retail Pharmacy

5.3. By Online Pharmacy

6. Latin America Cancer Immunotherapy Market - by End Use

6.1. By Hospitals & Clinics

6.2. By Cancer Research Centers

6.3. By Other End Uses

Chapter 8 Middle East & Africa Cancer Immunotherapy Market - Segment Analysis

1. Overview

2. Middle East & Africa Cancer Immunotherapy Market, 2021 - 2035 (USD Million)

3. Middle East & Africa Cancer Immunotherapy Market - by Product

3.1. By Monoclonal Antibodies

3.2. By Immunomodulators

3.3. By Oncolytic Viral Therapies & Cancer Vaccines

4. Middle East & Africa Cancer Immunotherapy Market - by Application

4.1. By Lung Cancer

4.2. By Breast Cancer

4.3. By Colorectal Cancer

4.4. By Melanoma

4.5. By Prostate Cancer

4.6. By Head & Neck Cancer

4.7. By Ovarian Cancer

4.8. By Pancreatic Cancer

4.9. By Other Cancers

5. Middle East & Africa Cancer Immunotherapy Market - by Distribution Channel

5.1. By Hospital Pharmacy

5.2. By Retail Pharmacy

5.3. By Online Pharmacy

6. Middle East & Africa Cancer Immunotherapy Market - by End Use

6.1. By Hospitals & Clinics

6.2. By Cancer Research Centers

6.3. By Other End Uses

Chapter 9 Key Market Dynamics

1. Introduction

2. Market Drivers

3. Market Restraints

4. Market Opportunities

5. Porter's Five Forces Analysis

6. PEST Analysis

7. Regulatory Landscape

8. Technology Landscape

9. Regional Market Trends

Chapter 10 COVID 19 Impact Analysis

1. Key strategies undertaken by companies to tackle COVID-19

2. Short term dynamics

3. Long term dynamics

Chapter 11 Marketing Strategy Analysis

1. Marketing Channel

2. Direct Marketing

3. Indirect Marketing

4. Marketing Channel Development Trends

Chapter 12 Competitive Landscape

1. Competition Matrix - 2021

2. Company Market Share Analysis - 2021

3. Key Company Activities, 2018 - 2021

4. Strategic Developments - Heat Map Analysis

5. Company Offering Evaluation

6. Company Regional Presence Evaluation

Chapter 13 Company Profiles

1. AstraZeneca (UK)

2. Merck & Co. Inc. (U.S.)

3. F. Hoffmann-La Roche Ltd. (Switzerland)

4. Immunocore Ltd. (UK)

5. Pfizer Inc. (U.S.)

6. Bristol-Myers Squibb Company (U.S.)

7. Novartis AG (Switzerland)

8. Eli Lilly & Company (U.S.)

9. Johnson & Johnson Services Inc. (U.S.)

Chapter 14 Key Primary Respondents - VERBATIM

Chapter 15 Discussion Guide

Chapter 16 Customization Offered

Chapter 17 Annexure

Chapter 18 List of Figures

Chapter 19 List of Tables

Chapter 20 List of Abbreviations

Certification 1

Certification 2

Certification 3

Customize your report

Check

Cross-Segment Market Size And Analysis For Mentioned Segments

Check

Additional Company Profiles (Upto 5 With No Cost)

Check

Additional Countries (Apart From Mentioned Countries)

Check

Country/Region-Specific Report

Check

Go To Market Strategy

Check

Region Specific Market Dynamics

Check

Region Level Market Share

Check

Import Export Analysis

Check

Others

FAQ‘s

Related Reports

Cancer Profiling Market

Neha Rathod Godbole

Cancer Profiling Market Size, Share & Trends Analysis Report by Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ...

From $ 4999

Smart Cancer Nanomedicine Market

Neha Rathod Godbole

Smart Cancer Nanomedicine Market Size, Share & Trends Analysis Report by Types (Artificial Intelligence, Machine Learning, Digital Health Tools, Others)...

From $ 4999

Pancreatic Cancer Therapy Market

Pancreatic Cancer Therapy Market Size, Share & Trends Analysis Report by Types (Biology, Chemotherapy, Targeted Therapy, Others) by Applications (Hospitals,...

From $ 4999

Non-hematological Cancer Treatment Market

Non-hematological Cancer Treatment Market Size, Share & Trends Analysis Report by Types (Chemotherapy, Surgery, Radiation Therapy, Others) by Applications (Hospitals,...

From $ 4999

Cancer/Oncology Drugs Market

Neha Rathod Godbole

Cancer/Oncology Drugs Market Size, Share & Trends Analysis Report by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer,...

From $ 4999

Multicancer Detection Market

Neha Rathod Godbole

Multicancer Detection Market Size, Share & Trends Analysis Report by Types (Laboratory Hospital, Clinicy Developed Tests (LDTs), In-Vitro Diagnostics (IVDs))...

From $ 4999

Company

About Us Services Contact Us Career

Quicklinks

How to order All reports Latest reports Upcoming reports Press Release Blogs

Support

Privacy Policy Terms of Service Cookie Policy FAQs

Contact

US Office:

224 W 35th St Ste 500, New York, NY 10001, United States

India Office:

Kamdhenu Jasmine, Main Road, Pimple Saudagar, Pune, Maharashtra, 411027

+1 (212) 951-1369

Toll Free Number+1 (877) 462-2282

sales@vantagemarketresearch.com

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

Follow Us

© 2025 Vantage Market Research. All right reserved

Secured By